Maximus vs MEDVi: Which GLP-1 Provider Is Better?

A side-by-side comparison of Maximus and MEDVi covering pricing, scores, medication types, insurance, and more to help you decide.

Maximus

#20 of 31
7.9/10

Men's performance and health platform offering GLP-1 alongside testosterone optimization and other protocols.

Visit Maximus
Higher Rated

MEDVi

#9 of 31
8.3/10

Compounded GLP-1 platform offering both oral and injectable options with flexible dosing and affordable pricing.

Visit MEDVi
FeatureMaximusMEDVi
Our Score7.9/108.3/10
Starting Price$99/mo$179/mo
Medication TypeCompoundedCompounded
Insurance AcceptedNoNo
Best ForMen who want GLP-1 alongside testosterone or other men's health protocolsUsers who want a low entry price with oral and injectable compounded options
Ranking#20#9

Pros & Cons Compared

Maximus

Pros

  • +Affordable pricing
  • +Men's health protocols
  • +Testosterone options
  • +Performance focus

Cons

  • Men only
  • Compounded only

MEDVi

Pros

  • +One of the few compounded providers offering both oral tablets and injectable semaglutide
  • +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
  • +Sleek onboarding experience with clear progress tracking through their patient portal
  • +$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

  • Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
  • No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

Our Verdict

MEDVi edges out Maximus with a score of 8.3/10 vs 7.9/10. If budget is your priority, Maximus starts at $99/mo compared to MEDVi's $179/mo. Choose Maximus if you want: men who want glp-1 alongside testosterone or other men's health protocols. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.

Try Maximus

Starting at $99/mo

Visit Maximus

Try MEDVi

Starting at $179/mo

Visit MEDVi